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Abstract Sonogashira reactions of steroids have been studied. The re-
action of α-estron-16-methylidenyloxy triflate with various alkynes af-
forded novel alkynylvinylidene steroids. The reactions proceeded in
good to quantitative yields, with excellent E-selectivity and with a broad
synthetic scope.
Key words estrone, steroids, Sonogashira coupling, palladium,
alkynes
Steroids are widespread in nature and fulfil functions
such as hormones or vitamins. They are incorporated in cell
membranes and are found in several bioactive compounds.
Hormones such as estrogens, which contain a characteristic
aromatic A-ring, are part of the signal system in several or-
ganisms. Estradiol as well as estrone and estratriol, in their
oxidized forms, have found many pharmaceutical applica-
tions.1 Undoubtedly, one of the most famous synthetic es-
trone derivatives is 17α-ethynylestradiol, which is a com-
ponent of contraceptive prescriptions.2 Other estrone de-
rivatives are known for their enzyme-inhibiting as well as
antiproliferative activity.3
Despite the intensive research on β-estrone derivatives,
reactions of α-estrones are much less studied.4 In general,
transition-metal-catalysed reactions of steroids have not
been widely studied to date. In fact, Sonogashira coupling
reactions of steroids have, to the best of our knowledge, not
been reported in the literature. Thus, due to our ongoing in-
terest related to the application of cross-coupling reactions
on the estrone framework,5 we were interested to study the
cross-coupling reaction of the α-estrone framework, partic-
ularly on 16-(hydroxymethylidene)-3-methoxy-α-estrone
(1), which was considered to be readily converted into its
corresponding triflate 2. In this regard we synthesized 2
from 1 using triflate anhydride, adapting a procedure
known for formylcyclopentanones.6 With this we acquired
our starting material in a good yield of 76% (Scheme 1).
Scheme 1  Synthesis of the starting material 2
Interestingly, during the reaction an isomerization oc-
curred and the E-isomer was formed with excellent selec-
tivity, which was additionally proven by X-ray crystallogra-
phy (Figure 1).7
Figure 1  ORTEP of 2
With triflate 2 in hand, we studied the Sonogashira re-
action (Table 1). Our initial attempts were unsuccessful. Re-
action of 2 with phenylacetylene under standard condi-
tions, namely the use of PdCl2(PPh3)2 and CuI as catalysts in
THF/NEt3, did not give the desired product (Table 1). Thus,
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get product 3a,  albeit, in low yield (15%). In contrast, 3a
was isolated in nearly quantitative yield when XPhos was
employed as the ligand.8 Interestlingly, the reaction pro-
ceeded very well at room temperature. Using this ligand al-
lowed us to reduce the catalyst loading to 2.5 mol% without
decrease of the yield, resulting in an excellent yield of 3a of
97%. Further reduction of the catalyst amount led to lower
yields.
Next, the scope of the reaction was studied (Scheme 2).
The developed conditions allow for the coupling of various
acetylenes and gave the desired products in moderate to ex-
cellent yields. Interestingly, the TMS group and a free amino
group are tolerated under the optimized reaction condi-
tions and lead to 3j and 3g in moderate to good yields of 45
and 69%, respectively. Furthermore, products containing a
thienyl moiety as well as an alkyl side chain were success-
fully synthesized in good yields of 70 and 61%, respectively.
The E-configuration of the products could not be specifical-
ly proven by NMR analysis; however, Sonogashira reactions
are generally well known to have a high stereospecificity.
Furthermore the vinylic proton of the products 3a–j shows
a coupling towards the nearest CH2 group of approximately
2.40 Hz. The same coupling constant could be found in
starting material 2.
In summary, we have synthesized (E)-16-(trifluoro-
methane-sulfonyloxymethylidene)-3-methoxy-α-estrone (2)
and applied it successfully in the Sonogashira reaction
under mild conditions. To the best of our knowledge, these
reactions represent the first examples of Sonogashira reac-
tions of steroids. The developed methodology9 is compati-
ble with the presence of various functional groups and gave
desired products in moderate to excellent yields.
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Compound 2 (0.225 mmol, 100 mg), CuI (0.006 mmol, 2.5 mol%,
Table 1  Optimization of the Sonogashira Reactiona
Catalyst 
[mol%]
Ligand [mol%] CuI 
[mol%]
Base Temp Time 
[h]
Yield 
[%]b
PdCl2(PPh3)2 
[5.0]
– 5 NEt3 65 °C 8 –
Pd(OAc)2 
[5.0]
P(tBu)3·HBF4
[10]
5 NEt3 r.t. 8 15
Pd(OAc)2 
[5.0]
XPhos [10] 5 NEt3 r.t. 8 95
Pd(OAc)2 
[5.0]
XPhos [10] 5 HN(iPr)2 r.t. 8 42
Pd(OAc)2 
[2.5]
XPhos [5] 2.5 NEt3 r.t. 6 97
Pd(OAc)2 
[1.5]
XPhos [3] 1.5 NEt3 r.t. 6 84
Pd(OAc)2 
[1.0]
XPhos [2] 1.0 NEt3 r.t. 6 74
Pd(OAc)2 
[0.5]
XPhos [1] 0.5 NEt3 r.t. 6 69
a Reaction conditions: 2 (0.225 mmol), CuI, Pd catalyst, ligand, phenyl 
acetylene (0.338 mmol), THF, base.
b Isolated yields.
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l.1.1 mg), Pd(OAc)2 (0.006 mmol, 2.5 mol%, 1.3 mg), XPhos (0.012
mmol, 5.0 mol%, 5.7 mg), and phenylacetylene (0.338 mmol, 35
mg) were dissolved in THF (5 mL) and NEt3 (1 mL). The reaction
mixture was stirred at r.t. for 6 h. The solution was diluted with
H2O and extracted with EtOAc (3×). The crude product was
purified by column chromatography on silica (elution system
heptane/EtOAc, 20:1). Yield: 86 mg (97%); mp 54–55 °C. 1H
NMR (250 MHz, CDCl3): δ = 0.79–0.88 (m, 3 H), 1.10 (s, 3 H, Me),
1.43–1.51 (m, 2 H), 1.76–1.83 (m, 1 H), 2.09–2.17 (m, 1 H),
2.24–2.32 (m, 2 H), 2.40–2.48 (m, 1 H), 2.79–2.92 (m, 3 H), 3.76
(s, 3 H, OMe), 6.59 (d, 4J = 2.71 Hz, 1 H), 6.67–6.72 (m, 2 H), 7.18
(d, 3J = 8.58 Hz, 1 H), 7.36–7.39 (m, 3 H), 7.50–7.54 (m, 2 H).13C
NMR (63 MHz, CDCl3): δ = 25.5 (CH3), 28.1, 28.3, 29.9, 30.3, 32.2
(CH2), 41.3, 43.0, 47.6 (CH), 50.8 (C), 55.2 (OCH3), 87.2, 101.0
(C≡C), 111.7, 113.5, 114.5 (CH), 122.7 (C), 126.9, 128.5, 129.2
(CH), 131.8 (C), 131.9 (CH), 138.0, 146.1, 157.5 (C), 207.4 (C=O).
IR (ATR,): 2918 (w), 2187 (w), 1711 (w), 1609 (w), 1498 (w),
1448 (w), 1257 (m), 1076 (m), 1016 (s), 870 (w), 793 (s), 755
(m), 688 (m), 531 (w) cm–1. MS (EI, 70 eV): m/z (%) = 397 (16),
396 (M+, 78), 227 (15), 210 (14), 186 (10), 178 (11), 174 (15),
173 (12), 165 (24), 160 (14), 158 (13), 153 (13), 152 (12), 147
(11), 145 (15), 144 (11), 141 (23), 140 (100), 139 (96), 129 (16),
128 (17), 126 (17), 115 (25), 114 (18), 102 (18), 91 (21), 65 (11).
ESI-HRMS: m/z calcd for  C28H29O [M + H+]: 397.21621; found:
397.21644.
Scheme 2  Synthesis of compounds 3a–j. Reagents and conditions: 2 (0.225 mmol), CuI (2.5 mol%), Pd(OAc)2 (2.5 mol%), XPhos (5.0 mol%), phenyl 
acetylene (0.338 mmol), THF, Et3N, r.t., 6 h; all isolated yields.
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